Qinghao Sheng

机构：Shandong Provincial Hospital, Shandong First Medical University · ORCID：0000-0001-5302-9139

发表论文 9 篇 · 总被引 176 次 · h-index 6

代表论文

• T cells and their products in diabetic kidney disease (2023 · Frontiers in Immunology · 被引 65)
• ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis (2023 · Redox Biology · 被引 58)
• N6-methyladenosine methylation in kidney injury (2023 · Clinical Epigenetics · 被引 17)
• The inhibition of ZC3H13 attenuates G2/M arrest and apoptosis by alleviating NABP1 m6A modification in cisplatin-induced acute kidney injury (2025 · Cellular and Molecular Life Sciences · 被引 10)
• FTO ‐mediated m6A modification of serum amyloid A2 mRNA promotes podocyte injury and inflammation by activating the NF‐κB signaling pathway (2024 · The FASEB Journal · 被引 10)
• Inhibition of the lncRNA 585189 prevents podocyte injury and mitochondria dysfunction by promoting hnRNP A1 and SIRT1 in diabetic nephropathy (2023 · Molecular and Cellular Endocrinology · 被引 8)